Cancer is the second most common cause of mortality and morbidity in kidney transplant
recipients after cardiovascular disease. Kidney transplant recipients have at least a twofold …

Kidney transplantation is the best possible treatment for many patients with end-stage renal
failure, but progressive dysfunction and eventual allograft loss with return to dialysis is …

Immunosuppression regimens used in solid organ transplant have evolved significantly over
the past 70 years in the United States. Early immunosuppression and targets for allograft …

Cytokines play an important role in host defense against microorganisms. They orchestrate
innate immunity by inducing protective local inflammation and systemic acute phase …

Abstract Context The European Association of Urology (EAU) panel on renal transplantation
(RT) has released an updated version of the RT guidelines. Objective To present the 2018 …

In kidney transplant recipients, cancer is one of the leading causes of death with a
functioning graft beyond the first year of kidney transplantation, and malignancies account …

Background Prolonging kidney transplant survival is an important clinical priority. Induction
immunosuppression with antibody therapy is recommended at transplantation and non …

Importance Among kidney transplant recipients, Black patients continue to have worse graft
function and reduced patient and graft survival. Better understanding of different phenotypes …

This study compared the incidence of CMV infection/disease in de novo kidney transplant
recipients receiving everolimus or mycophenolate and no CMV pharmacological …

Infection with human cytomegalovirus (CMV) is an important cause of morbidity and mortality
in kidney transplant recipients. CMV disease is diagnosed based on the detection of viral …